AFT and Salus Pharmaceuticals sign agreement for pain treatment Maxigesic IV

The agreement with Salus for the therapy covers Lithuania, Estonia, Latvia, Croatia, Slovenia, Serbia, North Macedonia, Montenegro, and Bosnia. Credit: National Cancer Institute on Unsplash.